Expression of the protein product of the PCPH proto-oncogene in human tumor cell lines

Radiation Research

Volumn 155, Issue 1, 2001, Pages 181-187

  Rouzaut, Ana ^a   Recio, Juan A ^a,b   Notario, Vicente ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISERUM; ENTPD5 PROTEIN, HUMAN; ENTPD5 PROTEIN, RAT; ONCOPROTEIN; RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL TRANSFORMATION; EPITHELIUM CELL; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; NEOPLASM; RABBIT; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL CELLS; GENE EXPRESSION; HUMANS; IMMUNE SERA; NEOPLASMS; ONCOGENE PROTEINS; RABBITS; RECOMBINANT PROTEINS; TUMOR CELLS, CULTURED;

EID: 0035219013     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/0033-7587(2001)155[0181:EOTPPO]2.0.CO;2     Document Type: Article

References (18)

1. Y. Berwald and L. Sachs, In vitro transformation of normal cells to tumor cells by carcinogenic hydrocarbons. J. Natl. Cancer Inst. 35, 641-661 (1965).
2. J. A. DiPaolo, P. J. Donovan and R. L. Nelson, In vitro transformation of hamster cells by polycyclic aromatic hydrocarbons: factors influencing the number of cells transformed. Nat. New Biol. 230, 240-242 (1971).
3. C. Borek, A. Ong and H. Mason, Distinctive transforming genes in X-ray transformed mammalian cells. Proc. Natl. Acad. Sci. USA 84, 794-798 (1987).
4. T. M. Gilmer, L. A. Annab and J. C. Barrett, Characterization of activated proto-oncogenes in chemically transformed Syrian hamster embryo cells. Mol. Carcinogen. 1, 180-188 (1988).
5. V. Notario, R. Castro, D. M. Flessate, J. Doniger and J. A. DiPaolo, Frequent activation of non-ras transforming sequences in neoplastic Syrian hamster cells initiated with chemical carcinogens. Oncogene 5, 1425-1430 (1990).
6. J. A. Velasco, R. Castro, M. A. Avila, J. Laborda, J. A. DiPaolo, J. Cansado and V. Notario, Cph, a novel oncogene which cooperates with H-ras in the transformation of NIH/3T3 fibroblasts. Oncogene 9, 2065-2069 (1994).
7. J. A. Velasco, D. B. Zimonjic, N. C. Popescu, J. Cansado, J. A. DiPaolo, A. Albor and V. Notario, Tissue-specific expression, evolutionary conservation and localization of the cph proto-oncogene on Syrian hamster chromosome X. Oncogene 12, 2713-2716 (1996).
8. J. A. Velasco, M. A. Avila and V. Notario, The product of the cph oncogene is a truncated, nucleotide binding protein that enhances cellular survival to stress. Oncogene 18, 689-701 (1999).
9. J. A. Recio, N. Zambrano, L. de la Peña, C. Powers, D. Siwarski, K. Huppi and V. Notario, cDNA isolation, expression, and chromosomal localization of the mouse Pcph proto-oncogene. Mol. Carcinogen. 26, 130-136 (1999).
10. J. A. Recio, N. Zambrano, L. de la Peña, J. A. Reig, A. Rhoads, A. Rouzaut and V. Notario, The human PCPH proto-oncogene; cDNA identification, primary structure, chromosomal mapping, and expression in normal and tumor cells. Mol. Carcinogen. 27, 229-236 (2000).
11. J. A. Recio, J. G. Paez, B. Maskeri, M. Loveland, J. A. Velasco and V. Notario, Both normal and transforming PCPH proteins have guanosine diphosphatase activity but only the oncoprotein cooperates with Ras in activating extracellular signal-regulated kinase ERK1. Cancer Res. 60, 1720-1728 (2000).
12. G. L. Chang and J. B. Little, In Radiation Carcinogenesis (A. C. Upton, R. E. Albert, E J. Burns and R. E. Shore, Eds.), pp. 107-136. Elsevier, New York, 1986.
13. C. Abeijon, K. Yanagisawa, E. C. Mandon, A. Häusler, K. Moremen, C. B. Hirschberg and P. W. Robbins, Guanosine diphosphatase is required for protein and sphingolipid glycosylation in the Golgi lumen of Saccharomyces cerevisiae. J. Cell Biol. 122, 307-323 (1993).
14. A. Albor, D. M. Flessate, T. Soussi and V. Notario, 3-Methylcholanthrene inactivates the p53 gene in Syrian hamster embryo fibroblasts by inducing a specific intronic point mutation. Cancer Res. 54, 4502-4507 (1994).
15. G. Otero, M. A. Avila, L. de la Peña, D. Emfietzoglou, J. Cansado, G. F. Popescu and V. Notario, Altered processing of precursor transcripts and increased levels of the subunit I of mitochondrial cytochrome c oxidase in Syrian hamster fetal cells initiated with ionizing radiation. Carcinogenesis 18, 1569-1575 (1997).
16. N. Cheung, M. P. Wong, S. T. Yuen, S. Y. Leung and L. P. Chung, Tissue-specific expression pattern of vascular endothelial growth factor isoform in the malignant transformation of lung and colon. Hum. Pathol. 29, 910-914 (1998).
17. R. Klaes, M. Kloor, F. Willeke, P. Melsheimer, M. von Knebel Doeberitz and R. Ridder, Significant increase of a specific variant TSG101 transcript during the progression of cervical neoplasia. Eur. J. Cancer 35, 733-777 (1999).
18. A. Kraus, E Neff, M. Behn, M. Schuermann, K. Muenkel and J. Schlegel, Expression of alternatively spliced mdm2 transcripts correlates with stabilized wild-type p53 protein in human glioblastoma cells. Int. J. Cancer 80, 930-934 (1999).